Albiges L - Search Results

1

A Case of Heavily Pretreated Metastatic Germ Cell Tumor With Ongoing Long-term Complete Response After Gemcitabine Treatment.

Vicier C, Baciarello G, Arfi-Rouche J, Massard C, Loriot Y, Albiges L, Cojean-Zelek I, Fizazi K. Vicier C, et al. Among authors: albiges l. Clin Genitourin Cancer. 2019 Jun;17(3):e485-e487. doi: 10.1016/j.clgc.2019.01.010. Epub 2019 Jan 26. Clin Genitourin Cancer. 2019. PMID: 30792009 No abstract available.

2

[Haematological complications of prostatic cancer: 2 cases, one revealing the neoplasia].

Albiges L, Cottu PH, Cojean-Zelek I, Raymond F, Zerkak D, Aerts J, Ziza JM. Albiges L, et al. Rev Med Interne. 2007 Mar;28(3):176-8. doi: 10.1016/j.revmed.2006.12.007. Epub 2007 Jan 3. Rev Med Interne. 2007. PMID: 17229492 French.

3

[New drugs in metastatic castration-resistant prostate cancer].

Albiges L, Loriot Y, Gross-Goupil M, de La Motte Rouge T, Blesius A, Escudier B, Massard C, Fizazi K. Albiges L, et al. Bull Cancer. 2010 Jan;97(1):149-59. doi: 10.1684/bdc.2009.1023. Bull Cancer. 2010. PMID: 20022854 French.

4

How to select targeted therapy in renal cell cancer.

Escudier B, Albiges L, Blesius A, Loriot Y, Massard C, Fizazi K. Escudier B, et al. Among authors: albiges l. Ann Oncol. 2010 Oct;21 Suppl 7:vii59-62. doi: 10.1093/annonc/mdq371. Ann Oncol. 2010. PMID: 20943644 Free article. Review.

5

Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen.

Edeline J, Loriot Y, Culine S, Massard C, Albiges L, Blesius A, Escudier B, Fizazi K. Edeline J, et al. Among authors: albiges l. Eur J Cancer. 2012 May;48(8):1141-6. doi: 10.1016/j.ejca.2012.01.022. Epub 2012 Feb 22. Eur J Cancer. 2012. PMID: 22364733

6

False positive 2-(18)Fluroro-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with disseminated seminoma and post-chemotherapy residual masses.

Wagner M, Bellmunt J, Boutros C, Bonardel G, Loriot Y, Albiges L, Massard C, Fizazi K. Wagner M, et al. Among authors: albiges l. Clin Genitourin Cancer. 2013 Mar;11(1):66-9. doi: 10.1016/j.clgc.2012.06.006. Epub 2012 Sep 13. Clin Genitourin Cancer. 2013. PMID: 22981209 No abstract available.

7

Novel and bone-targeted agents for CRPC.

Fizazi K, Albiges L, Massard C, Escudier B, Loriot Y. Fizazi K, et al. Among authors: albiges l. Ann Oncol. 2012 Sep;23 Suppl 10:x264-7. doi: 10.1093/annonc/mds353. Ann Oncol. 2012. PMID: 22987974 Free article.

8

How to select amongst available options for the treatment of advanced RCC?

Escudier B, Albiges L, Massard C, Loriot Y, Fizazi K. Escudier B, et al. Among authors: albiges l. Ann Oncol. 2012 Sep;23 Suppl 10:x309-12. doi: 10.1093/annonc/mds352. Ann Oncol. 2012. PMID: 22987982 Free article.

9

Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients.

Levy A, Menard J, Albiges L, Loriot Y, Di Palma M, Fizazi K, Escudier B. Levy A, et al. Among authors: albiges l. Eur J Cancer. 2013 May;49(8):1898-904. doi: 10.1016/j.ejca.2013.02.003. Epub 2013 Mar 13. Eur J Cancer. 2013. PMID: 23490648

10

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).

Loriot Y, Bianchini D, Ileana E, Sandhu S, Patrikidou A, Pezaro C, Albiges L, Attard G, Fizazi K, De Bono JS, Massard C. Loriot Y, et al. Among authors: albiges l. Ann Oncol. 2013 Jul;24(7):1807-1812. doi: 10.1093/annonc/mdt136. Epub 2013 Apr 10. Ann Oncol. 2013. PMID: 23576708 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters